Literature DB >> 15270739

Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

Helen A Fletcher1, Patrick Owiafe, David Jeffries, Philip Hill, Graham A W Rook, Alimuddin Zumla, T Mark Doherty, Roger H Brookes.   

Abstract

Expression of interleukin (IL)-4 is increased in tuberculosis and thought to be detrimental. We show here that in healthy contacts there is increased expression of its naturally occurring antagonist, IL-4delta2 (IL-4delta2). We identified contacts by showing that their peripheral blood mononuclear cells (PBMC) released interferon (IFN)-gamma in response to the Mycobacterium tuberculosis-specific antigen 6 kDa early secretory antigenic target (ESAT-6). Fresh unstimulated PBMC from these contacts contained higher levels of mRNA encoding IL-4delta2 (P=0.002) than did cells from ESAT-6 negative donors (noncontacts). These data indicate that contact with M. tuberculosis induces unusual, previously unrecognized, immunological events. We tentatively hypothesize that progression to active disease might depend upon the underlying ratio of IL-4 to IL-4delta2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270739      PMCID: PMC1782524          DOI: 10.1111/j.1365-2567.2004.01922.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Cloning of interleukin-4 delta2 splice variant (IL-4delta2) in chimpanzee and cynomolgus macaque: phylogenetic analysis of delta2 splice variant appearance, and implications for the study of IL-4-driven immune processes.

Authors:  Isabelle Gautherot; Nicolas Burdin; Delphine Seguin; Luc Aujame; Régis Sodoyer
Journal:  Immunogenetics       Date:  2002-11-12       Impact factor: 2.846

2.  Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients.

Authors:  S M Smith; M R Klein; A S Malin; J Sillah; K P W J McAdam; H M Dockrell
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

3.  Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease.

Authors:  A Wangoo; T Sparer; I N Brown; V A Snewin; R Janssen; J Thole; H T Cook; R J Shaw; D B Young
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

4.  Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia.

Authors:  J Vekemans; C Lienhardt; J S Sillah; J G Wheeler; G P Lahai; M T Doherty; T Corrah; P Andersen; K P McAdam; A Marchant
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4delta2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR.

Authors:  G T Seah; G A Rook
Journal:  J Immunol Methods       Date:  1999-08-31       Impact factor: 2.303

6.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.

Authors:  A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

7.  Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities.

Authors:  R van Crevel; E Karyadi; F Preyers; M Leenders; B J Kullberg; R H Nelwan; J W van der Meer
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma.

Authors:  G T Seah; P S Gao; J M Hopkin; G A Rook
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

9.  Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.

Authors:  Sandra M Arend; Krista E van Meijgaarden; Kirsten de Boer; Elisabeth Cerdá de Palou; Dick van Soolingen; Tom H M Ottenhoff; Jaap T van Dissel
Journal:  J Infect Dis       Date:  2002-11-19       Impact factor: 5.226

10.  Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo.

Authors:  Christian Lienhardt; Annalisa Azzurri; Amedeo Amedei; Katherine Fielding; Jackson Sillah; Oumou Y Sow; Boubacar Bah; Marisa Benagiano; Alimou Diallo; Roberto Manetti; Kebba Manneh; Per Gustafson; Steve Bennett; Mario M D'Elios; Keith McAdam; Gianfranco Del Prete
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

View more
  27 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 4.  The molecular mechanism of human resistance to HIV-1 infection in persistently infected individuals--a review, hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

5.  A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.

Authors:  Patricia Price; Niamh M Keane; Silvia Lee; Andrew F Y Lim; Elizabeth J McKinnon; Martyn A French
Journal:  Immunology       Date:  2006-06-22       Impact factor: 7.397

6.  Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Authors:  Rabia Hussain; Najeeha Talat; Ambreen Ansari; Firdaus Shahid; Zahra Hasan; Ghaffar Dawood
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

7.  Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma.

Authors:  Irina G Luzina; Virginia Lockatell; Sachin Lavania; Edward M Pickering; Phillip H Kang; Yulia N Bashkatova; Sergey M Andreev; Sergei P Atamas
Journal:  Cytokine       Date:  2012-01-15       Impact factor: 3.861

8.  Effect of vitamin D supplementation on cathelicidin, IFN-γ, IL-4 and Th1/Th2 transcription factors in young healthy females.

Authors:  M Das; N Tomar; V Sreenivas; N Gupta; R Goswami
Journal:  Eur J Clin Nutr       Date:  2014-01-08       Impact factor: 4.016

9.  Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Authors:  Rogelio Hernández-Pando; Diana Aguilar; Hector Orozco; Yuriria Cortez; Laura Rosa Brunet; Graham A Rook
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

10.  Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis.

Authors:  Maria Teresa Herrera; Martha Torres; Denarra Nevels; Carlos Núñez Perez-Redondo; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Tuberculosis (Edinb)       Date:  2008-10-09       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.